A carregar...
Farnesoid X Receptor Agonist Represses Cytochrome P450 2D6 Expression by Upregulating Small Heterodimer Partner
Cytochrome P450 2D6 (CYP2D6) is a major drug-metabolizing enzyme responsible for eliminating approximately 20% of marketed drugs. Studies have shown that differential transcriptional regulation of CYP2D6 may contribute to large interindividual variability in CYP2D6-mediated drug metabolism. However,...
Na minha lista:
| Publicado no: | Drug Metab Dispos |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The American Society for Pharmacology and Experimental Therapeutics
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4468439/ https://ncbi.nlm.nih.gov/pubmed/25926433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.115.064758 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|